recombinant thrombomodulin

From Aaushi
Jump to navigation Jump to search

Contraindications

Adverse effects

More general terms

References

  1. Vincent JL, Francois B, Zabolotskikh I et al. Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: The SCARLET randomized clinical trial. JAMA. 2019;321(20):1993-2002 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31104069 https://jamanetwork.com/journals/jama/fullarticle/2733995